Oslo 01.07.2013 – The study was recently presented by Prof. Lars Østergaard from Aarhus University Hospital at Bionor Pharma’s Capital Markets Day in Oslo, 14 June.
See article in the Danish newspaper Berlingske 30 June about the research with HDAC Inhibitors in HIV patients, presented at the conference in Kuala Lumpur: http://www.b.dk/nationalt/dansk-gennembrud-i-kampen-mod-hiv#
See also information at Aarhus University Hospital’s website about this research: http://www.auh.dk/presse/information+om+auh/nyheder/visnyhed?visNyhed=128049